RKRebecca L. Kinney

Rebecca L. Kinney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rebecca L. Kinney has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Abdulkadir Omer

    Department of Endocrinology, Regenerative and Restorative Medicine Research Centre, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey

    1 shared publication
  • Ariana Kamberi

    Division of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States

    1 shared publication
  • Daniel J. Amante

    Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts, USA

    1 shared publication
  • Erin Borglund

    UMass Medical School UMass Medical School UMass Medical School UMass Medical School UMass Medical School UMass Medical School University of Alabama

    1 shared publication
  • Jane S. Saczynski

    Department of Quantitative Health Sciences, University of Massachusetts, Medical School, Worcester, USA; Department of Medicine, University of Massachusetts, Medical School, Worcester, USA

    1 shared publication
  • Mary Beth Dziewietin

    University of Massachusetts Medical School

    1 shared publication

Latest Publications

  • Open Access

    How do features of Electronic Health Records Impact Prescription of Nicotine Replacement Therapy?

    by Thomas English, Daniel Amante, Erin Borglund, Ariana Kamberi, Rajani Sadasivam, Rebecca Kinney, Thomas Houston

    Nicotine Replacement Therapy (NRT) is an effective medication to help patients quit smoking tobacco. Yet, 18% of adults in the United States still smoke cigarettes. With advancements in health technology and improved features within electronic health record (EHR) systems, it is crucial to understand how differences in EHR features influence the prescribing of NRT. We conducted a cross-sectional study of 174 primary care practices to better understand how EHR features, including drug reference databases in EHRs, were associated with NRT prescribing at a practice level. Regression models were created to understand NRT prescribing patterns among clinics with varying EHR features and found that practices using an EHR with a drug reference database were 2.3 times more likely to view NRT as a high priority for treating smokers. Use of NRT in primary care differs significantly in relation to the capability of a clinic's technology. Clinics with more EHR features, specifically EHR drug reference databases, favored NRT. Our study suggests that pharmacotherapy could become the preferred activity in smoking cessation treatment, as EHR-integrated drug reference database prevalence increases.

  • Predicting Remission of Diabetes After RYGB Surgery Following Intensive Management to Optimize Preoperative Glucose Control

    by Thomas MacAndrew English, Samir Malkani, Rebecca L. Kinney, Abdulkadir Omer, Mary Beth Dziewietin, Richard Perugini

    The purpose of the study is to investigate the association of preoperative glucose optimization prior to a Roux-en-Y gastric bypass (RYGB) and diabetes remission. The study is a retrospective review of 245 patients with a history of diabetes type II and a RYGB from 2008 to 2012 at UMass Memorial Hospital. Patients that benefited from glucose optimization prior to RYGB were more likely to achieve diabetes remission 1 year after surgery. The preoperative glucose optimization intervention demonstrated that when patients decreased their HbA1c prior to surgery by 1 %, these individuals were 68 % more likely to remit (p = 0.015). Duration of diabetes (p = 0.005) and insulin use (p < 0.001) were also significant predictors of remission, whereas age, race, and gender were not. Our study results indicate that a greater degree of glycemic improvement in response to presurgical medical intervention is associated with higher rates of diabetes remission post-operatively among obese adults with diabetes type II. Conversely, the lack of favorable glycemic response to intensification of medical management predicts a poor glycemic response to bariatric surgery. Further research is needed to determine if this difference is due to physiological factors or is simply an indicator of patient behavior.